Education
About Us
Working with TipRanks
Follow Us
Centessa Pharmaceuticals (CNTA)
NASDAQ:CNTA
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 6.85M | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 6.85M | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -201.06M | $ -171.28M | $ -212.26M | $ -374.87M | $ -10.44M |
| EBITDA | $ -221.88M | $ -165.43M | $ -209.55M | $ -139.30M | $ -10.29M |
| Net Income | $ -235.76M | $ -151.09M | $ -216.21M | $ -381.90M | $ -10.66M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 482.18M | $ 256.55M | $ 393.64M | $ 595.08M | $ 7.23M |
| Total Assets | $ 576.80M | $ 360.25M | $ 444.31M | $ 629.63M | $ 11.72M |
| Total Debt | $ 117.23M | $ 84.59M | $ 69.80M | $ 75.70M | $ 5.63M |
| Net Debt | $ -266.00M | $ -43.44M | $ -323.84M | $ -519.38M | $ -1.60M |
| Total Liabilities | $ 175.25M | $ 124.00M | $ 108.14M | $ 138.08M | $ 8.62M |
| Stockholders' Equity | $ 401.55M | $ 236.24M | $ 336.17M | $ 491.55M | $ 3.10M |
| Cash Flow | |||||
| Free Cash Flow | $ -142.09M | $ -160.51M | $ -201.68M | $ -136.33M | $ -10.63M |
| Operating Cash Flow | $ -142.06M | $ -160.34M | $ -200.55M | $ -136.14M | $ -10.63M |
| Investing Cash Flow | $ 31.27M | $ -127.00M | $ -931.00K | $ 63.25M | $ 0.00 |
| Financing Cash Flow | $ 364.75M | $ 21.12M | $ 457.00K | $ 660.07M | $ 1.36M |